ARK kidney

Status of development

Kidney and liver preclinical studies with a pig model have been finished and the final version of the ARK device is already available for mass manufacturing. The company holds an ISO13485 certification and the ARK kidney device is granted with the CE mark that allows its commercialization in the EU countries. The certification of the device under the FDA requirements willl be faced in the upcoming months.

EBERS was founded in 2009 by a group of members of the University of Zaragoza led by Pedro Moreo (LinkedIn) and Víctor Alastrué (LinkedIn), who left the academic world to start the business. Still today Pedro and Víctor run the company as CEO and CTO, respectively.

In the beginning, EBERS was focused on the design and fabrication of advanced laboratory equipment for cell culture, with a special emphasis on tissue and organ engineering and 3D cell culture applications. This continues being an active business line of the company, with cell culture products being sold to academic and research customers all over the world and new products being launched frequently.

In 2014 EBERS decided to expand its business by entering the medical device market with a new technology for ex vivo organ preservation. This decision was motivated in first place by the demands of transplant surgeons for better systems for organ preservation. Also, the management team of the company was convinced that the know-how and experience acquired by EBERS in the field of tissue and organ regeneration would be valuable to develop excellent products for organ preservation.

This website is exclusively dedicated to the business line of EBERS dealing with medical technology for organ preservation. If you are interested in our cell culture products, we encourage you to visit our alternative site, where you will find updated detailed information on the rest of our product lines.